BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24394002)

  • 21. [Experience of Ramucirumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer in Our Hospital].
    Hagino S; Miyata T; Sakamoto K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1559-1561. PubMed ID: 29394701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of pathologically complete response in a patient with locally advanced sigmoid colon cancer after chemotherapy including bevacizumab/FOLFOX4].
    Mikami Y; Tamura N; Akiyama M; Muraoka T; Sakurai U; Sawabe M
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):777-9. PubMed ID: 25129094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of rectal endocrine cell carcinoma treated by laparoscopic assisted intersphincteric resection after neoadjuvant chemotherapy].
    Wakatsuki K; Yoshioka S; Shiobara M; Kataoka M; Arai S; Tonooka T; Miyazawa K; Oeda Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2026-8. PubMed ID: 24394001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.
    Schwartzberg LS; Rivera F; Karthaus M; Fasola G; Canon JL; Hecht JR; Yu H; Oliner KS; Go WY
    J Clin Oncol; 2014 Jul; 32(21):2240-7. PubMed ID: 24687833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Radical Resection of Rectal Cancer with Multiple Liver and Lung Metastases after Preoperative Chemotherapy].
    Yamashita S; Shimizu Y; Tominaga H; Kimura Y; Odagiri K; Kurokawa T; Yamaguchi M; Takahashi G; Sawada G; Moon J; Inoue M; Irei T; Nakahira S; Hatanaka N
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1274-6. PubMed ID: 26489570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of locally advanced rectal cancer responding to FOLFOX].
    Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two cases of curative resection by laparoscopic surgery following preoperative chemotherapy with bevacizumab for locally advanced colon cancer].
    Sakaguchi M; Kan T; Tsubono M; Kii E
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):503-7. PubMed ID: 24743370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.
    Graham CN; Hechmati G; Hjelmgren J; de Liège F; Lanier J; Knox H; Barber B
    Eur J Cancer; 2014 Nov; 50(16):2791-801. PubMed ID: 25219451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical resection after chemotherapy for advanced rectal cancer - report of a case].
    Suda K; Kameyama H; Shimada Y; Sakata J; Kobayashi T; Nogami H; Minagawa M; Kosugi S; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1572-4. PubMed ID: 25731256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of locally advanced sigmoid colon cancer invading the bladder and seminal vesicle effectively treated with preoperative mFOLFOX6].
    Hirayama K; Hayashi T; Nishiwaki Y; Kamishima M; Furuhashi S; Fukushima H; Nakata Y; Tamura H; Kanai T; Ikematsu Y; Mori H; Ozawa T
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2663-6. PubMed ID: 22189239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A successful treatment of conversion chemotherapy by mFOLFOX6 plus cetuximab for initially unresectable synchronous colorectal liver metastases].
    Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Kuboki S; Miyazaki M
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1853-6. PubMed ID: 22083196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Liver Metastasis from Colorectal Cancer That Showed a Pathological Complete Response to mFOLFOX6 plus Cetuximab].
    Konishi K; Ikenaga M; Ohta K; Nakashima S; Nakagawa T; Endo S; Yamada T; Chihara T; Nishijima J
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):1003-7. PubMed ID: 27539045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial.
    Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Wu X; Peng J; Ren D; Wang J
    J Clin Oncol; 2019 Dec; 37(34):3223-3233. PubMed ID: 31557064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Curative Resection after Neoadjuvant Chemotherapy for Locally-Advanced Sigmoid Colon Carcinoma with Urinary Bladder Invasion].
    Sato Y; Kobayashi M; Karasawa H; Ichikawa H; Kajiwara T; Kohyama A; Watanabe K; Kamei T; Ohnuma S; Unno M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1764-1766. PubMed ID: 35046323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.
    Ducreux M; Bennouna J; Hebbar M; Ychou M; Lledo G; Conroy T; Adenis A; Faroux R; Rebischung C; Bergougnoux L; Kockler L; Douillard JY;
    Int J Cancer; 2011 Feb; 128(3):682-90. PubMed ID: 20473862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two Cases of Rectal Cancer Resected Curatively after Chemotherapy with CapeOX plus Bmab].
    Chiku T; Sano W; Hashiba T; Togawa Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1647-9. PubMed ID: 26805125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A patient with sigmoid colon cancer( cStage IV) who responded to preoperative chemotherapy with mFOLFOX6 plus bevacizumab and was subsequently able to undergo a radical operation].
    Kaneko J; Aoyagi H; Yoshida T; Iwata N; Hasegawa K; Yamamoto H; Oshida K; Takahata T; Maejima S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2204-6. PubMed ID: 23268024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.